137 related articles for article (PubMed ID: 35659482)
1. Guideline discordant care in patients with metastatic germ cell tumors.
Lin JK; Jacobs LA; Blauch A; Shulman LN; Vaughn DJ
Urol Oncol; 2022 Aug; 40(8):385.e9-385.e17. PubMed ID: 35659482
[TBL] [Abstract][Full Text] [Related]
2. Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy.
Kliesch S; Schmidt S; Wilborn D; Aigner C; Albrecht W; Bedke J; Beintker M; Beyersdorff D; Bokemeyer C; Busch J; Classen J; de Wit M; Dieckmann KP; Diemer T; Dieing A; Gockel M; Göckel-Beining B; Hakenberg OW; Heidenreich A; Heinzelbecker J; Herkommer K; Hermanns T; Kaufmann S; Kornmann M; Kotzerke J; Krege S; Kristiansen G; Lorch A; Müller AC; Oechsle K; Ohloff T; Oing C; Otto U; Pfister D; Pichler R; Recken H; Rick O; Rudolph Y; Ruf C; Schirren J; Schmelz H; Schmidberger H; Schrader M; Schweyer S; Seeling S; Souchon R; Winter C; Wittekind C; Zengerling F; Zermann DH; Zillmann R; Albers P
Urol Int; 2021; 105(3-4):181-191. PubMed ID: 33486494
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
4. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
5. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
[TBL] [Abstract][Full Text] [Related]
6. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
7. Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours.
Thibault C; Fizazi K; Barrios D; Massard C; Albiges L; Baumert H; Patard JJ; Escudier B; Loriot Y
Eur J Cancer; 2014 May; 50(7):1284-90. PubMed ID: 24560488
[TBL] [Abstract][Full Text] [Related]
8. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of testicular germ cell tumors relapse].
Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
[TBL] [Abstract][Full Text] [Related]
10. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract][Full Text] [Related]
11. Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).
De Giorgi U; Richard S; Badoglio M; Kanfer E; Bourrhis JH; Nicolas-Virelizier E; Vettenranta K; Lioure B; Martin S; Dreger P; Schuler MK; Thomson K; Scarpi E; Rosti G; Selle F; Mangili G; Lanza F; Bregni M;
Ann Oncol; 2017 Aug; 28(8):1910-1916. PubMed ID: 28510616
[TBL] [Abstract][Full Text] [Related]
12. Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
Kliesch S; Schmidt S; Wilborn D; Aigner C; Albrecht W; Bedke J; Beintker M; Beyersdorff D; Bokemeyer C; Busch J; Classen J; de Wit M; Dieckmann KP; Diemer T; Dieing A; Gockel M; Göckel-Beining B; Hakenberg OW; Heidenreich A; Heinzelbecker J; Herkommer K; Hermanns T; Kaufmann S; Kornmann M; Kotzerke J; Krege S; Kristiansen G; Lorch A; Müller AC; Oechsle K; Ohloff T; Oing C; Otto U; Pfister D; Pichler R; Recken H; Rick O; Rudolph Y; Ruf C; Schirren J; Schmelz H; Schmidberger H; Schrader M; Schweyer S; Seeling S; Souchon R; Winter C; Wittekind C; Zengerling F; Zermann DH; Zillmann R; Albers P
Urol Int; 2021; 105(3-4):169-180. PubMed ID: 33412555
[TBL] [Abstract][Full Text] [Related]
13. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
17. Epidemiology, Management, and Survival Outcomes of Germ Cell Cancer in Southern Portugal: A Population-Based Study (2008-2012).
Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
[TBL] [Abstract][Full Text] [Related]
18. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
Veenstra CM; Vaughn DJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis.
Nason GJ; Donahoe L; de Perrot M; Aditya I; Jewett MAS; Bedard PL; Hansen AR; Chung P; Warde P; Anson-Cartwright L; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
Urology; 2020 Apr; 138():69-76. PubMed ID: 32004556
[TBL] [Abstract][Full Text] [Related]
20. The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors.
Oing C; Lorch A
Oncol Res Treat; 2018; 41(6):365-369. PubMed ID: 29843143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
